IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Memorial Sloan Kettering Cancer Center

Q4 2020 Holdings

Filed 2021-02-16 | 4 holdings | $236.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Royalty Pharma PLC(RPRX)SHS CL AG7709Q104$178.5K3,565,88775.6%
Vaneck Vectors ETF TR(GDX)GOLD MINERS ETF92189F106$26.6K738,50011.3%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$20.4K602,2728.6%
Y-Mabs Therapeutics Inc(YMABUSD)COM984241109$10.7K216,9164.5%